KR20160041949A - 손상 조직의 재생 - Google Patents

손상 조직의 재생 Download PDF

Info

Publication number
KR20160041949A
KR20160041949A KR1020167005263A KR20167005263A KR20160041949A KR 20160041949 A KR20160041949 A KR 20160041949A KR 1020167005263 A KR1020167005263 A KR 1020167005263A KR 20167005263 A KR20167005263 A KR 20167005263A KR 20160041949 A KR20160041949 A KR 20160041949A
Authority
KR
South Korea
Prior art keywords
wound
elastin
trough
tissue
edge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020167005263A
Other languages
English (en)
Korean (ko)
Inventor
안토니 스티븐 바이스
Original Assignee
엘라스타겐 피티와이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903092A external-priority patent/AU2013903092A0/en
Application filed by 엘라스타겐 피티와이 리미티드 filed Critical 엘라스타겐 피티와이 리미티드
Priority to KR1020217040694A priority Critical patent/KR102488446B1/ko
Publication of KR20160041949A publication Critical patent/KR20160041949A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
KR1020167005263A 2013-08-13 2014-08-13 손상 조직의 재생 Ceased KR20160041949A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217040694A KR102488446B1 (ko) 2013-08-13 2014-08-13 손상 조직의 재생

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013903092 2013-08-13
AU2013903092A AU2013903092A0 (en) 2013-08-13 Regeneration of damaged tissue
PCT/AU2014/050180 WO2015021508A1 (en) 2013-08-13 2014-08-13 Regeneration of damaged tissue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217040694A Division KR102488446B1 (ko) 2013-08-13 2014-08-13 손상 조직의 재생

Publications (1)

Publication Number Publication Date
KR20160041949A true KR20160041949A (ko) 2016-04-18

Family

ID=52467858

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020167005263A Ceased KR20160041949A (ko) 2013-08-13 2014-08-13 손상 조직의 재생
KR1020227045816A Abandoned KR20230004965A (ko) 2013-08-13 2014-08-13 손상 조직의 재생
KR1020217040694A Active KR102488446B1 (ko) 2013-08-13 2014-08-13 손상 조직의 재생

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020227045816A Abandoned KR20230004965A (ko) 2013-08-13 2014-08-13 손상 조직의 재생
KR1020217040694A Active KR102488446B1 (ko) 2013-08-13 2014-08-13 손상 조직의 재생

Country Status (12)

Country Link
US (4) US20160194379A1 (enExample)
EP (2) EP3033099B1 (enExample)
JP (3) JP6382311B2 (enExample)
KR (3) KR20160041949A (enExample)
CN (2) CN110464837A (enExample)
AU (3) AU2014306362B2 (enExample)
BR (1) BR112016003082A8 (enExample)
CA (1) CA2920312C (enExample)
ES (1) ES2965893T3 (enExample)
MX (2) MX377200B (enExample)
RU (1) RU2677637C2 (enExample)
WO (1) WO2015021508A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
US10842913B2 (en) 2012-12-10 2020-11-24 Allergan Pharmaceuticals International Limited Scalable three-dimensional elastic construct manufacturing
RU2677637C2 (ru) * 2013-08-13 2019-01-18 Эластаджен Пти Лтд Регенерация поврежденной ткани
HK1257488A1 (zh) * 2015-09-01 2019-10-25 Allergan Pharmaceuticals International Limited 骨形成
BR112019008509A2 (pt) * 2016-11-04 2019-07-09 Allergan Pharmaceuticals Int Ltd dispositivos biossintéticos
AU2020270005A1 (en) * 2019-05-03 2022-01-06 Allergan Pharmaceuticals International Limited Scar prevention and/or treatment
WO2022076117A1 (en) * 2020-09-08 2022-04-14 Protein Genomics Inc. Biomimetic wound healing devices and related methods of treating diabetic wounds

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675387A (en) 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
FI903489A7 (fi) 1988-11-11 1990-07-10 Medical Res Council Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
ES2097806T3 (es) 1990-03-30 1997-04-16 Shiseido Co Ltd Procedimiento para purificar un polipeptido.
CA2145278C (en) 1992-09-25 2009-03-10 Commonwealth Scientific And Industrial Research Organisation Target binding polypeptide
JP3474190B2 (ja) * 1992-12-22 2003-12-08 ザ ユニバーシテイ オブ シドニイ 合成ポリヌクレオチド
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) * 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
AU728480B2 (en) 1996-08-07 2001-01-11 Hospital For Sick Children, The Self-aligning peptides derived from elastin and other fibrous proteins
AUPO156596A0 (en) * 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
CA2279902C (en) 1997-02-07 2009-01-13 Sisters Of Providence In Oregon Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US20030009013A1 (en) 1998-12-30 2003-01-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6667051B1 (en) * 1999-05-28 2003-12-23 Kenton W. Gregory Methods for producing elastin, and tropoelastin products for repairing and or replacing tissue
AU1375301A (en) 1999-11-15 2001-05-30 Bio Syntech Canada Inc Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
US20050244393A1 (en) 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) * 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US20040110439A1 (en) 2001-04-20 2004-06-10 Chaikof Elliot L Native protein mimetic fibers, fiber networks and fabrics for medical use
US7125960B2 (en) 2001-05-30 2006-10-24 Chisso Corporation Crosslinked elastin and process for producing the same
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US7641643B2 (en) 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
FR2855969B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US7666829B2 (en) 2004-02-20 2010-02-23 Human Matrix Sciences, Llc Compositions for elastogenesis and connective tissue treatment
US7192043B1 (en) 2004-05-25 2007-03-20 Mcluen Design, Inc. Multi-terrain wheel chair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US20060062768A1 (en) 2004-09-23 2006-03-23 Olexander Hnojewyj Biocompatible hydrogel compositions
WO2006098024A1 (ja) 2005-03-16 2006-09-21 Fujitsu Limited Ipネットワークにおけるマルチキャストツリー監視方法およびシステム
CA2602947A1 (en) 2005-03-24 2006-09-28 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
KR100785378B1 (ko) 2005-09-05 2007-12-14 주식회사 바이오레인 다층구조의 유착방지제
JP2009512508A (ja) 2005-10-19 2009-03-26 グレゴリー，ケントン・ダブリュー トロポエラスチンの使用および生産方法、およびトロポエラスチン生体材料
US7770126B2 (en) 2006-02-10 2010-08-03 Microsoft Corporation Assisting user interface element use
US8518105B2 (en) 2006-03-24 2013-08-27 Abbott Cardiovascular System Inc. Methods and apparatuses for coating a lesion
US20070237735A1 (en) 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
DK2656832T3 (en) 2006-05-11 2019-04-08 Regenics As Compositions for use in wound healing
US20070287741A1 (en) 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
US8846624B2 (en) 2006-09-11 2014-09-30 Emory University Modified protein polymers
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
WO2008058323A1 (en) * 2006-11-13 2008-05-22 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
US20090136438A1 (en) * 2007-07-25 2009-05-28 Dermaplus, Inc. Photo-protective dermatological formulations and methods of using the same
WO2009018546A1 (en) 2007-08-02 2009-02-05 Medicis Pharmaceutical Corporation Method of applying an injectable filler
FR2920968B1 (fr) 2007-09-14 2009-11-13 Oreal Procede cosmetique de traitement esthetique et/ou reparateur de la peau
US9421305B2 (en) 2008-02-01 2016-08-23 Wake Forest University Health Sciences Aligned scaffolding system for skeletal muscle regeneration
US8469961B2 (en) 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
US8080265B2 (en) 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
WO2010102337A1 (en) * 2009-03-10 2010-09-16 The University Of Sydney Injectable biomaterials
EP4062950A1 (en) 2010-03-22 2022-09-28 Allergan, Inc. Syringe comprising dermal filler for soft tissue augmentation
WO2011127478A1 (en) 2010-04-09 2011-10-13 Nanovasc, Inc. Sleeve for graft and method
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof
US9611312B2 (en) 2010-11-23 2017-04-04 Elastagen Pty. Limited Preparation and/or formulation of proteins cross-linked with polysaccharides
GB201021438D0 (en) 2010-12-16 2011-02-02 Imp Innovations Ltd Layered fibrous construct
DK3505180T3 (da) 2011-09-30 2022-09-19 Allergan Pharmaceuticals Int Ltd In vivo-syntese af elastisk fiber
US9114128B2 (en) * 2011-09-30 2015-08-25 Protein Genomics, Inc. Tropoelastins and uses thereof
WO2014063194A1 (en) * 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
US10842913B2 (en) 2012-12-10 2020-11-24 Allergan Pharmaceuticals International Limited Scalable three-dimensional elastic construct manufacturing
RU2677637C2 (ru) * 2013-08-13 2019-01-18 Эластаджен Пти Лтд Регенерация поврежденной ткани
JP6694381B2 (ja) 2013-09-24 2020-05-13 エラスタジェン・プロプライエタリー・リミテッドＥｌａｓｔａｇｅｎ Ｐｔｙ Ｌｔｄ タンパク質抽出方法

Also Published As

Publication number Publication date
EP3033099B1 (en) 2023-11-01
US20250171522A1 (en) 2025-05-29
ES2965893T3 (es) 2024-04-17
MX2020011880A (es) 2021-01-20
US20190062405A1 (en) 2019-02-28
US11084867B2 (en) 2021-08-10
JP2018164789A (ja) 2018-10-25
JP6382311B2 (ja) 2018-08-29
CN110464837A (zh) 2019-11-19
EP4316537A2 (en) 2024-02-07
JP2020049282A (ja) 2020-04-02
CA2920312C (en) 2022-07-19
AU2014306362B2 (en) 2019-04-18
BR112016003082A2 (pt) 2017-08-01
AU2019204972A1 (en) 2019-08-01
MX2016001436A (es) 2016-07-05
RU2016104618A3 (enExample) 2018-06-18
JP6891257B2 (ja) 2021-06-18
JP6639587B2 (ja) 2020-02-05
AU2014306362A1 (en) 2016-02-18
AU2021245202B2 (en) 2025-01-23
BR112016003082A8 (pt) 2020-01-28
RU2677637C2 (ru) 2019-01-18
WO2015021508A1 (en) 2015-02-19
CN105530951B (zh) 2019-10-22
US20220098281A1 (en) 2022-03-31
MX377200B (es) 2025-03-07
KR20210154881A (ko) 2021-12-21
US20160194379A1 (en) 2016-07-07
KR102488446B1 (ko) 2023-01-13
CN105530951A (zh) 2016-04-27
EP3033099A1 (en) 2016-06-22
CA2920312A1 (en) 2015-02-19
EP3033099A4 (en) 2017-04-12
AU2021245202A1 (en) 2021-11-04
JP2016527979A (ja) 2016-09-15
AU2019204972B2 (en) 2021-07-08
EP4316537A3 (en) 2024-04-10
RU2016104618A (ru) 2017-09-14
KR20230004965A (ko) 2023-01-06

Similar Documents

Publication Publication Date Title
US20250171522A1 (en) Regeneration of damaged tissue
Lorenz et al. Wounds: biology, pathology, and management
Kakudo et al. Platelet-rich plasma promotes epithelialization and angiogenesis in a splitthickness skin graft donor site
De Vries et al. Dermal regeneration in native non‐cross‐linked collagen sponges with different extracellular matrix molecules
JP2015533798A5 (enExample)
US20240293596A1 (en) Compositions and methods for treating wounds
JP6316943B2 (ja) 鼓膜治癒のためのヘパリン結合性上皮成長因子活性の調節法
HK40016252A (zh) 受损组织的再生
Lorenz et al. Wounds: Biology
Nath A Clinical Study on the Efficacy of Autologous Platelet Rich Plasma in the Management of Chronic Non Healing Ulcers
최진일 Assessment of Wound Healing Efficacy of Porcine Placental Amniotic Membrane Derived Extracellular Matrix
Hrynyk Enhanced burn wound healing through controlled and sustained delivery of bioactive insulin from alginate sponge dressings
Kuroyanagi et al. Tissue-engineered products capable of enhancing wound healing
Lorenz et al. Wounds: Biology, Pathology, and
CHERRY et al. HEALING PHASES
Charles et al. 19 Active Treatments for Acute and Chronic Wounds

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160226

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20190611

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20190612

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190724

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20201114

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210629

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20201114

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20210629

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20210215

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20190724

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20211012

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20210830

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20210629

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20210215

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20201114

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20190724

X601 Decision of rejection after re-examination
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20211210

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20211213

WITB Written withdrawal of application